The Feasibility of Pressurised Intraperitoneal Aerosolised Virotherapy (PIPAV) to Administer Oncolytic Adenoviruses.
Sophia J TateLeen Van de SandeWim P CeelenJared TorkingtonAlan L ParkerPublished in: Pharmaceutics (2021)
PIPAV appears viable and well tolerated, though in vivo efficacy requires further optimisation.
Keyphrases